Podrobno

Cross-species upregulation of MAGED2 in liver cancer suggests a role in obesity-driven tumor progression
ID Bayat, Tara (Avtor), ID Blagotinšek Cokan, Kaja (Avtor), ID Rozman, Damjana (Avtor), ID Fon Tacer, Klementina (Avtor), et al.

.pdfPDF - Predstavitvena datoteka, prenos (3,09 MB)
MD5: E94D0D6233D13ABC9279BF34033EB321
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1467-3045/48/2/139 Povezava se odpre v novem oknu

Izvleček
Melanoma-associated antigens (MAGEs) are cancer-testis antigens (CTAs) aberrantly expressed in multiple cancer types, including hepatocellular carcinoma (HCC), and associated with aggressive phenotypes. Although MAGE proteins are widely studied as cancer immunotherapy targets, their roles in HCC and the regulation of their expression during liver pathogenesis in mouse models, including dietary effects, remain poorly understood. We analyzed Mage gene expression in liver tissues from 78 C3H/HeJ mice with chronic diet-induced obesity. While type I MAGE genes are frequently expressed in human HCC, we found no evidence of their expression in mouse liver tumors, suggesting species-specific regulation. In contrast, type II Maged2, previously reported to be upregulated in human HCC, was significantly increased in mouse liver tumors. Analysis of human HCC samples from The Cancer Genome Atlas (TCGA) database confirmed MAGED2 upregulation and its association with patient prognosis. Together, these findings identify MAGED2 as a conserved marker of liver cancer in both humans and mice and emphasize the importance of cross-species comparative approaches for selecting appropriate models and accurately interpreting results, particularly for CTAs, which often evolved recently and in a species-specific manner.

Jezik:Angleški jezik
Ključne besede:cancer-testis antigen, CTA, comparative cancer research, hepatocellular carcinoma, high-fat diet, liver tumors, melanoma-associated antigen, MAGE, obesity
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:23 str.
Številčenje:Vol. 48, iss. 2, art. 139
PID:20.500.12556/RUL-182429 Povezava se odpre v novem oknu
UDK:616.36-006:613.25
ISSN pri članku:1467-3045
DOI:10.3390/cimb48020139 Povezava se odpre v novem oknu
COBISS.SI-ID:277413635 Povezava se odpre v novem oknu
Datum objave v RUL:11.05.2026
Število ogledov:142
Število prenosov:137
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Current issues in molecular biology
Skrajšan naslov:Curr. issues mol. biol.
Založnik:MDPI
ISSN:1467-3045
COBISS.SI-ID:521769497 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:antigen raka testisov, CTA, primerjalne raziskave raka, hepatocelularni karcinom, prehrana z visoko vsebnostjo maščob, tumorji jeter, z melanomom povezan antigen, MAGE, debelost

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0390
Naslov:Funkcijska genomika in biotehnologija za zdravje

Financer:Empirical Foods Inc.
Številka projekta:A18-0187

Financer:TTUAB
Program financ.:Grants-in-Aid

Financer:Cancer Prevention and Research Institute of Texas
Številka projekta:RR200059

Financer:Texas Tech University
Program financ.:Start-up

Financer:Texas Tech University, School of Veterinary Medicine
Program financ.:Seed award

Financer:TC3R - Texas Center for Comparative Cancer Research

Financer:Foundation for Prader–Willi Syndrome Research
Številka projekta:22-0321

Financer:Foundation for Prader–Willi Syndrome Research
Številka projekta:23-0447

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj